U.S. Markets closed

Bausch Health Inc (BHC) CHAIRMAN & CEO Joseph C Papa Bought $699,300 of Shares

CHAIRMAN & CEO of Bausch Health Inc (30-Year Financial, Insider Trades) Joseph C Papa (insider trades) bought 30,000 shares of BHC on 09/13/2019 at an average price of $23.31 a share. The total cost of this purchase was $699,300.


Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices. Bausch Health Companies Inc has a market cap of $8.2 billion; its shares were traded at around $23.24 with and P/S ratio of 0.96. Bausch Health Companies Inc had annual average EBITDA growth of 17.50% over the past ten years. GuruFocus rated Bausch Health Companies Inc the business predictability rank of 3.5-star. GuruFocus has detected 3 severe warning signs with Bausch Health Companies Inc. .

CEO Recent Trades:

  • CHAIRMAN & CEO Joseph C Papa bought 30,000 shares of BHC stock on 09/13/2019 at the average price of $23.31. The price of the stock has decreased by 0.3% since.

Directors and Officers Recent Trades:

  • President, Ortho-Dermatologics William D. Humphries bought 30,703 shares of BHC stock on 08/16/2019 at the average price of $21.18. The price of the stock has increased by 9.73% since.
  • President, Salix Mark C. Mckenna sold 10,773 shares of BHC stock on 08/19/2019 at the average price of $21.83. The price of the stock has increased by 6.46% since.

For the complete insider trading history of BHC, click here

.This article first appeared on GuruFocus.